Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients

Borae Geum Park, Younhee Park, Dong Jin Joo, Kyu Ha Huh, Myoung Soo Kim, Soon Il Kim, Yu Seun Kim, Hyon Suk Kim

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Background: The presence of donor-specific antibodies (DSAs) to human leukocyte antigen (HLA) increases the risk of antibody- mediated rejection (ABMR) after kidney transplantation (KT). However, the clinical relevance of anti-HLA-DR51/52/53 antibodies remains unclear because of their weak antigen expression. This study evaluated the association between anti- HLA-DR51/52/53 DSAs and ABMR. Methods: We retrospectively reviewed the single-antigen-bead panel reactive antibody (single PRA) results of 130 patients tested between August 1, 2009 and March 6, 2015, based on clinical necessity after allograft KT. Single PRA analysis was performed using Luminex assay kits (Lifecodes LSA class I and II). We reviewed the clinical course and biopsy results of patients with anti- HLA-DR51/52/53 DSAs. Results: Post-KT DSAs were identified in 89 of the 130 patients (68.5%), with 26 of 32 class I DSAs and 63 of 66 class II DSAs being immunodominant DSAs. Thirteen patients had anti-HLA-DR51/52/53 DSAs. Three patients with anti-HLA-DR51/52/53 immunodominant DSAs alone were diagnosed with biopsy-proven ABMR. One patient who developed anti-HLA-DR DSA 13 days after KT showed a rapid increase in anti-HLA-DR51 DSA and had biopsy-proven ABMR. Conclusions: Although the expression of the HLA-DR51/52/53 antigen was weak, anti-HLA-DR51/52/53 DSAs might be correlated with biopsy-proven ABMR. Therefore, anti-HLA-DR51/52/53 DSAs must be evaluated as a cause of ABMR after transplantation.

Original languageEnglish
Pages (from-to)47-54
Number of pages8
JournalKorean Journal of Transplantation
Issue number3
Publication statusPublished - 2019 Sep 30

Bibliographical note

Funding Information:
This study was supported by a faculty research grant from Yonsei University College of Medicine (6-2015-0081).

Publisher Copyright:
© 2021 Korean Journal of Transplantation. All rights reserved.

All Science Journal Classification (ASJC) codes

  • Immunology
  • Transplantation


Dive into the research topics of 'Clinical significance of donor-specific anti-HLA-DR51/52/53 antibodies for antibody-mediated rejection in kidney transplant recipients'. Together they form a unique fingerprint.

Cite this